BridgeMD
New treatment option for Lung Cancer
Official title Health Education Approach to Lung Screening
ClinicalTrials.gov ID: NCT06070870
What this study is testing
- What it's testing
- Evaluate the impact of the patient navigation program on the proportion of patients who complete lung cancer screening (LCS), defined as undergoing a low dose computed tomography (LDCT)
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 to 80. Healthy volunteers may be eligible.
You may be able to join if
- Meets current USPSTF guidelines for lung cancer screening (LCS)
- 20 pack-year smoking history Note: A pack-year is a way of calculating how much a person has smoked in their lifetime. One pack-year is the...
- Currently smokes or has quit smoking within the past 15 years
- Identifies as Black or African-American Note: Both Hispanic/Latino and Non-Hispanic/Latino patients are eligible as long as they also identify as...
- Willing to complete all navigation-related study activities
You likely can't join if
- A patient who meets any of the following exclusion criteria is ineligible to participate in the study:
- Known history of cancer (except squamous cell skin cancer), or coughing up blood in the past 5 years, as reported by the individual
- Has undergone a previous lung cancer screening
- Inability to speak English
- Medical, psychological, or social condition that, in the opinion of the investigator, may increase the patient's risk or limit the patient's...
See the full eligibility criteria
- Meets current USPSTF guidelines for lung cancer screening (LCS)
- 20 pack-year smoking history Note: A pack-year is a way of calculating how much a person has smoked in their lifetime. One pack-year is the equivalent of smoking an average of 20 cigarettes-1 pack-per day for a year.
- Currently smokes or has quit smoking within the past 15 years
- Identifies as Black or African-American Note: Both Hispanic/Latino and Non-Hispanic/Latino patients are eligible as long as they also identify as Black or African-American (eg, Afro-Latino).
- Willing to complete all navigation-related study activities
- Able to understand and the willingness to sign a written informed consent document
- A patient who meets any of the following exclusion criteria is ineligible to participate in the study:
- Known history of cancer (except squamous cell skin cancer), or coughing up blood in the past 5 years, as reported by the individual
- Has undergone a previous lung cancer screening
- Inability to speak English
- Medical, psychological, or social condition that, in the opinion of the investigator, may increase the patient's risk or limit the patient's adherence with study requirements
The study team makes the final eligibility decision.
Where it's taking place
- Carrboro, North Carolina, United States
- Charleston, South Carolina, United States
- Richmond, Virginia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years to 80 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Carrboro, North Carolina, United States; Charleston, South Carolina, United States; Richmond, Virginia, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.